Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Interventions for seborrhoeic dermatitis

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD008138Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 07 October 2009see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Skin Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Enembe O Okokon

    Correspondence to: Department of Community Health, University of Calabar Teaching Hospital, Calabar, Nigeria

    [email protected]

  • Angela Oyo‐Ita

    Department of Community Health, University of Calabar Teaching Hospital, Calabar, Nigeria

  • Olivier Chosidow

    Department of Dermatology, Hôpital Henri Mondor, Paris, France

Contributions of authors

Linking with editorial base and co‐ordinate contributions from co‐authors ‐ EOO
Drafting protocol ‐ EOO (with contributions from OC)
Running search ‐ EOO
Identify relevant titles and abstracts from searches ‐ EOO and OC
Obtaining copies of trials ‐ EOO
Selecting which trials to include ‐ EOO
Extracting data from trials ‐ EOO and OC
Carrying out analysis ‐ EOO
Interpreting analysis ‐ EOO, OC, and AO

Sources of support

Internal sources

  • The Nigerian Branch of the South African Cochrane Centre, Nigeria.

    Capacity building in research synthesis by way of a training workshop on protocol development

External sources

  • No sources of support supplied

Declarations of interest

Olivier Chosidow acts as a consultant for Pierre Fabre which markets ciclopiroxolamine (he was co‐author of 2 RCTs which involved the product). He was involved in an RCT involving lithium which was supported by Labcatal. He was invited to an international board by Janssen Cilag (Sterala) which markets ketoconazole foam. He is a co author of a book on the topic which will be published in the last trimester of 2009.

None of the other authors involved in this review have declared commercial interests.

Acknowledgements

The authors would like to thank Erin Dixon and Martin Meremikwu for their help.

The Cochrane Skin Group editorial base would like to thank Robert Dellavalle who acted as Key Editor, Jo Leonardi‐Bee as Statistics Editor, Philippa Middleton as Methods Editor, Camille Angeles who was the external content peer referee, and Shirley Manknell who was the consumer referee on this protocol.

Version history

Published

Title

Stage

Authors

Version

2015 May 02

Topical antifungals for seborrhoeic dermatitis

Review

Enembe O Okokon, Jos H Verbeek, Jani H Ruotsalainen, Olumuyiwa A Ojo, Victor Nyange Bakhoya

https://doi.org/10.1002/14651858.CD008138.pub3

2015 Apr 28

Topical antifungals for seborrhoeic dermatitis

Review

Enembe O Okokon, Jos H Verbeek, Jani H Ruotsalainen, Olumuyiwa A Ojo, Victor Nyange Bakhoya

https://doi.org/10.1002/14651858.CD008138.pub2

2009 Oct 07

Interventions for seborrhoeic dermatitis

Protocol

Enembe O Okokon, Angela Oyo‐Ita, Olivier Chosidow

https://doi.org/10.1002/14651858.CD008138

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.